Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 41 record(s)

Req # A-2023-00032

Provide the following briefing document: MIN-PF230116-00567

Organization: Pacific Economic Development Canada

0 page(s)
September 2023

Req # A-2021-024942

Provide all emails sent to/from/cc'ing Douglas Clarke between May 1 to December 16, 2021. Exclude media scans.

Organization: Patented Medicine Prices Review Board Canada

3229 page(s)
September 2023

Req # A-2023-36126

When referring to page numbers below, I mean the pages in the Client Package disclosed under A-2022-05111. Specifically, I would like to request the following: 1. The "Board deck" (presumably a PowerPoint presentation) mentioned on pages 21-27. 2. The powerpoint attached to the email on page 47, which apparently deals with discrepancies between dTCC data. 3. The media lines attached to the email on page 95. 4. The excel sheet attached to the email on page 98. 5. The presentation attached to the email on page 135. 6. Both attachments to the email on page 135, plus the two documents that are linked to in the email: the impact estimates and communication plan. 7. The attachment to the email on page 142. 8. The "Key messages" document linked to in the body of the email on page 145. 9. The Excel file attached to the email on page 165. 10. I would like any contextual documents related to the document which appears on pages 359-360 ("Brochure: 2020 Rent Increase Guidelines). I imagine this was an attachment to an email, in which case I would like the email (possibly pages 4368-4369 of the raw request). I would also like to request any other documents related to how the brochure was located by the PMPRB, or what use was made of the Brochure by the PMPRB (like subsequent email discussions or meeting agendas which list this document, or reports or memos written about this document, etc). In each case, I would like the most recent or final version. I do not need drafts. Please exclude cabinet confidences.

Organization: Patented Medicine Prices Review Board Canada

17 page(s)
September 2023

Req # A-2022-00034

Provide the following briefing document: PAC220322-00126

Organization: Pacific Economic Development Canada

3 page(s)
September 2022

Req # A-2022-00037

Provide the following briefing document: MIN-PF220408-00280

Organization: Pacific Economic Development Canada

29 page(s)
September 2022

Req # A-2022-00038

Provide the following briefing document: PAC220405-00131

Organization: Pacific Economic Development Canada

6 page(s)
September 2022

Req # A-2022-00047

Provide the following briefing document: MIN-PF220513-00317

Organization: Pacific Economic Development Canada

27 page(s)
September 2022

Req # A-2022-00049

Provide the following briefing document: MIN-PF220517-00318

Organization: Pacific Economic Development Canada

103 page(s)
September 2022

Req # A-2022-00052

Provide the following briefing document: MIN-PF220607-00339

Organization: Pacific Economic Development Canada

29 page(s)
September 2022

Req # A-2022-01918

Copies of the number of every patent reported to the PMPRB, via Form 1 Patent List or otherwise, with respect to Keytruda pembrolizumab.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
September 2022
Date modified: